Search -

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Presenter: Ignacio Amat-Santos

October 28, 2024